NGVT
Ingevity Corp
NYSE: NGVT · BASIC MATERIALS · SPECIALTY CHEMICALS
$74.44
-0.15% today
Updated 2026-06-05
Market cap
$2.50B
P/E ratio
—
P/S ratio
2.13x
EPS (TTM)
$-4.29
Dividend yield
—
52W range
$40 – $79
Volume
0.2M
WallStSmart proprietary scores
47
out of 100
Grade: C
Sell
Investment rating
5.3
Growth
C+4.0
Quality
C5.5
Profitability
C+3.7
Valuation
D6/9
Piotroski F-Score
Moderate
1.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$85.50
+14.86%
12-Month target
—
—
Intrinsic (DCF)
$45.46
Margin of safety
-64.78%
1 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Altman Z 0.96 — distress zone
- Thin margins at -10.80%
- Negative free cash flow $-12.30M
- 64.78% above intrinsic value
- Debt/equity 32.00x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.67B | $1.69B | $1.41B | $1.17B | $1.18B |
| Net income | $211.60M | $-5.40M | $-430.30M | $-167.10M | $59.80M |
| EPS | — | — | — | — | $-4.29 |
| Free cash flow | $170.90M | $95.30M | $51.00M | $273.50M | $-12.30M |
| Profit margin | 12.68% | -0.32% | -30.60% | -14.31% | -10.80% |
Peer comparison
Smart narrative
Ingevity Corp trades at $74.44. Our Smart Value Score of 47/100 indicates the stock is fair. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of 0.96, it sits in the distress. TTM revenue stands at $1.18B. with profit margins at -10.80%. Our DCF model estimates intrinsic value at $45.46.
Frequently asked questions
What is Ingevity Corp's stock price?
Ingevity Corp (NGVT) trades at $74.44, on a P/S of 2.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Ingevity Corp overvalued?
Ingevity Corp carries a Smart Value Score of 47/100 (Grade C), which we rate Sell. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $45.46 against the $74.44 price, so on cash flow terms the market is paying a premium for Ingevity Corp's growth. The Sell rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Ingevity Corp (NGVT)?
The 12-month analyst consensus target is $85.50, about 14.9% above the current $74.44. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Ingevity Corp (NGVT)?
Our DCF model estimates intrinsic value at $45.46, a -64.8% margin of safety versus today's $74.44. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Ingevity Corp's revenue?
Ingevity Corp's trailing twelve-month revenue is $1.18B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Ingevity Corp's Altman Z-Score is 0.96, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorBASIC MATERIALS
IndustrySPECIALTY CHEMICALS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio2.13x
ROE-328.53%
Beta1.19
50D MA$71.62
200D MA$63.37
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—